UN Watchdog Warns of Unprecedented Spike in Dangerous New Synthetic Drugs
A 2026 UNODC report highlights a significant global rise in drug use, reaching 331 million people. Authorities warn of an unprecedented surge in dangerous synthetic substances, as trafficking routes shift and new psychoactive drugs emerge to evade international regulatory frameworks and detection efforts.
Highlights
- •Global drug usage increased to 331 million people by 2024, representing 6.2% of the population aged 15-64.
- •There is an unprecedented spike in highly potent synthetic drugs like fentanyls, nitazenes, and orphines.
- •The number of new psychoactive substances (NPS) reached 755 in 2024, with 118 appearing for the first time.
- •A shift from plant-based opiates to synthetics is occurring following the 2022 opium ban in Afghanistan.
A recent report released by the United Nations Office on Drugs and Crime (UNODC) has issued a stark warning regarding the global surge in the use of new synthetic drugs. As international markets grapple with these evolving challenges, the 2026 World Drug Report indicates that approximately 331 million people were active drug users in 2024. This figure represents 6.2 percent of the global population aged 15 to 64, marking a significant rise from the 5.2 percent recorded in 2014.
Rising Concerns Over New Synthetic Drugs
The latest data highlights that while cannabis remains the most frequently consumed substance worldwide, there is an alarming trend toward the proliferation of potent, new synthetic drugs. Officials have noted that drug producers are increasingly creative in their efforts to bypass existing regulations and avoid detection. This cat-and-mouse game between authorities and manufacturers has led to the emergence of highly dangerous substances, including various forms of fentanyls, nitazenes, and orphines, which are often marketed as substitutes for heroin.
Monica Juma, the head of the UNODC, emphasized that the market is witnessing an unprecedented spike in the variety of substances available. The report revealed that in 2024, the number of new psychoactive substances (NPS) circulating globally reached 755, with 118 of these appearing on the market for the first time. Authorities reported that drug seizures in 2024 identified five times as many distinct drug types compared to the period before the year 2000.
Market Shifts and Global Ramifications
The global landscape for narcotics is also shifting due to significant supply chain disruptions. The 2022 ban on poppy cultivation implemented by the Taliban in Afghanistan has drastically altered the supply of opium and heroin. Consequently, drug traffickers are pivotally turning toward synthetic alternatives. The UNODC warns that this transition away from plant-based opiates could result in a permanent change within the international opioid market, bringing unknown long-term harms.
Furthermore, the report details the expansion of new markets for methamphetamine, primarily manufactured in Myanmar, with additional production hubs identified in North America, Africa, and Southwest Asia. Cannabis usage continues to climb steadily, partly due to evolving legal frameworks and decriminalization efforts across various jurisdictions. Between 2014 and 2024, the number of cannabis users grew by 40 percent. Meanwhile, cocaine production has quadrupled over the past decade, with traffickers actively pushing to establish new demand in Africa and Asia, alongside their traditional strongholds in Europe, America, and Oceania.
